Availability of NMP22 (Nuclear matrix protein 22) for the diagnosis of urothelial cancer

Acta Urologica Japonica

Volumn 47, Issue 5, 2001, Pages 307-310

  Akagashi, Keigo ^a   Tanda, Hitoshi ^a   Kato, Shuji ^a   Ohnishi, Shigeki ^a   Nakajima, Hisao ^a   Nanbu, Akihito ^a   Nitta, Toshikazu ^a   Koroku, Mikio ^a  

^a Sanjukai Hospital   (Japan)

Author keywords

Nuclear matrix protein 22 (NMP22); Urinary cytology; Urothelial cancer

Indexed keywords

NUCLEAR MATRIX PROTEIN 22; NUCLEAR PROTEIN; TUMOR MARKER;

ARTICLE; BLADDER TUMOR; CYTOLOGY; FEMALE; HUMAN; KIDNEY PELVIS; KIDNEY TUMOR; MALE; PREDICTION AND FORECASTING; SENSITIVITY AND SPECIFICITY; URETER TUMOR; URINARY TRACT CANCER; URINE;

FEMALE; HUMANS; KIDNEY NEOPLASMS; KIDNEY PELVIS; MALE; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS; URINE; UROLOGIC NEOPLASMS;

EID: 3342998467     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Zippe C, Pandrangi L and Agarwal A : NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer. J Urol 161 : 62-65, 1999
2. Miller TE, Beausang LA, Winchell LF, et al. : Detection of nuclear matrix proteins in serum from cancer patients. Cancer Res 52 : 422-427, 1992
3. Ramakumar S, Bhuiyan J, Besse JA, et al. : Comparison of screening methods in the detection of bladder cancer. J Urol 161 : 388-394, 1999
4. Miyanaga N, Akaza H, Ishikawa S, et al. : Clinical evaluation of nuclear matrix protein 22 (NMP22) in urine as a novel marker for urothelial cancer. Eur Urol 31 : 163-168, 1997
5. Konchuba AM, Schellhammer PK, Alexander JP, et al. : Flow cytometric study comparing paired bladder washing and voided urine for bladder cancer detection. Urology 33 : 89-96, 1989
6. Sarosdy MF, White RWD, Soloway MS, et al.: Results of a multicenter trial uring the BTA test to monitor for and diagnose recurrent bladder cancer. J Urol 154 : 379-384, 1995
7. Soloway MS, Briggman JV, Carpinito GA, et al. : Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J Urol 156 : 363-367, 1996
8. Abbate I, D'introno A, Cardo G, et al. : Comparison of nuclear matrix protein 22 and bladder tumor antigen in urine of patients with bladder cancer. Anticancer Res 18 : 3803-3806, 1998
9. Stampfer DS, Carpinito GA, Rodriguez-Villanueva J, et al. : Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder. J Urol 159 : 394-398, 1998